
ResMed (RMD) Stock Forecast & Price Target
ResMed (RMD) Analyst Ratings
Bulls say
ResMed is experiencing strong revenue growth through device and mask sales, and an expanding gross margin has propelled its FY26 revenue and earnings above expectations. Additionally, ResMed's strategic focus on digital health positions it to benefit from the growing demand for out-of-hospital care. However, potential competition in international markets and uncertainties around operating expenses may give some investors pause.
Bears say
ResMed is facing challenges in its growth potential due to a slowing market for respiratory care devices, which is reflected in its underperformance in key regions like Europe, Asia and other international markets. The company is also facing increased expenses, driven in part by acquisitions, which is weighing on its earnings. Management's lowered growth outlook for its Residential Care Software segment also raises concerns about the company's future growth potential.
This aggregate rating is based on analysts' research of ResMed and is not a guaranteed prediction by Public.com or investment advice.
ResMed (RMD) Analyst Forecast & Price Prediction
Start investing in ResMed (RMD)
Order type
Buy in
Order amount
Est. shares
0 shares